Page last updated: 2024-10-26

erythrosine and Carcinoma, Lewis Lung

erythrosine has been researched along with Carcinoma, Lewis Lung in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hermans, IF1
Ritchie, DS1
Yang, J1
Roberts, JM1
Ronchese, F1

Other Studies

1 other study available for erythrosine and Carcinoma, Lewis Lung

ArticleYear
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
    Journal of immunology (Baltimore, Md. : 1950), 2000, Mar-15, Volume: 164, Issue:6

    Topics: Animals; Antigens, Neoplasm; Antigens, Viral; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Cel

2000